Page last updated: 2024-08-24

plerixafor and Allergic Reaction

plerixafor has been researched along with Allergic Reaction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abboud, D; Boeglin, D; Bonnet, D; Daubeuf, F; Frossard, N; Galzi, JL; Gasparik, V; Gizzi, P; Hachet-Haas, M; Haiech, J; Heissler, D; Hibert, M; Knehans, T; Lehalle, C; Marsol, C; Regenass, P; Riché, S; Rognan, D; Rohmer, F; Villa, P	1
Berlin, A; Bridger, GJ; Lukacs, NW; Schols, D; Skerlj, RT	1

Other Studies

2 other study(ies) available for plerixafor and Allergic Reaction

Article	Year
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia. Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CXCL12; Disease Models, Animal; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Male; Mice, Inbred BALB C; Models, Molecular; Pyrimidinones; Receptors, CXCR4; Structure-Activity Relationship	2018
AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. The American journal of pathology, 2002, Volume: 160, Issue:4 Topics: Allergens; Animals; Benzylamines; Bronchial Hyperreactivity; Cell Movement; Chemokines; Cyclams; Cytokines; Female; Heterocyclic Compounds; Hypersensitivity; Leukocytes; Mice; Mice, Inbred CBA; Pneumonia; Receptors, CXCR4	2002

Article

Year

Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.

Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CXCL12; Disease Models, Animal; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Male; Mice, Inbred BALB C; Models, Molecular; Pyrimidinones; Receptors, CXCR4; Structure-Activity Relationship

2018

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

The American journal of pathology, 2002, Volume: 160, Issue:4

Topics: Allergens; Animals; Benzylamines; Bronchial Hyperreactivity; Cell Movement; Chemokines; Cyclams; Cytokines; Female; Heterocyclic Compounds; Hypersensitivity; Leukocytes; Mice; Mice, Inbred CBA; Pneumonia; Receptors, CXCR4

2002